Randomized clinical trial on accelerated hyperfractionated versus hypofractionated preoperative radiotherapy for rectal cancer: A report on perioperative complication rates

被引:0
|
作者
Wzietek, Iwona
Bialas, Marcin
Kryj, Mariusz
Chmielarz, Andrzej
Widel, Maciej
Idasiak, Adam
Namysl-Kaletka, Agnieszka
Stobiecka, Ewa
Chmielik, Ewa
Wydmanski, Jerzy
Suwinski, Rafal
机构
[1] Maria Sklodowska Curie Mem Canc Ctr, Gliwice, Poland
[2] Inst Oncol, Gliwice, Poland
[3] Maria Sklodowska Curie Mem Canc Ctr, Dept Tumor Pathol, Gliwice, Poland
[4] Inst Oncol, Gliwice Branch, Gliwice, Poland
关键词
D O I
10.1200/jco.2013.31.4_suppl.506
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
506
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Randomized clinical trial on accelerated preoperative hyperfractionated radiotherapy versus preoperative hyperfractionated radio-chemotherapy in locally advanced rectal cancer
    Idasiak, Adam
    Ziolkowska, Barbara
    Rajczykowski, Marcin
    Galwas, Katarzyna
    Debosz-Suwinska, Iwona
    Zeman, Marcin
    Mrochem-Kwarciak, Jolanta
    Suwinski, Rafal
    BRITISH JOURNAL OF RADIOLOGY, 2024, 97 (1163): : 1879 - 1889
  • [2] RANDOMIZED CLINICAL TRIAL ON HYPERFRACTIONATED VS. HYPOFRACTIONATED PREOPERATIVE RADIOTHERAPY FOR RECTAL CANCER: PRELIMINARY EVALUATION OF PERIOPERATIVE ADVERSE EVENTS
    Wzietek, I.
    Idasiak, A.
    Namysl-Kaletka, A.
    Kryj, M.
    Chmielarz, A.
    Wydmanski, J.
    Rafal, S.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S290 - S290
  • [3] Randomized Clinical Trial on Hyperfractionated Versus Hypofractionated Preoperative Radiotherapy for Rectal Cancer: Long Term Outcomes Including Quality of Life Assessment
    Wzietek, I.
    Kryj, M.
    Idasiak, A.
    Bialas, M.
    Chmielarz, A.
    Miszczyk, L.
    Tukiendorf, A.
    Stobiecka, E.
    Chmielik, E.
    Wydmanski, J.
    Namysl-Kaletka, A.
    Gabrys, D.
    Suwinski, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S21 - S21
  • [5] Preoperative hyperfractionated accelerated radiotherapy in locally advanced rectal cancer
    Notter, M
    Bühlmann, M
    Hueber, C
    Schlumpf, R
    Bodis, S
    STRAHLENTHERAPIE UND ONKOLOGIE, 2005, 181 : 133 - 133
  • [6] THE RATIONALE TO SWITCH FROM POSTOPERATIVE HYPERFRACTIONATED ACCELERATED RADIOTHERAPY TO PREOPERATIVE HYPERFRACTIONATED ACCELERATED RADIOTHERAPY IN RECTAL-CANCER
    COUCKE, PA
    SARTORELLI, B
    CUTTAT, JF
    JEANNERET, W
    GILLET, M
    MIRIMANOFF, RO
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 32 (01): : 181 - 188
  • [7] Pathologic tumor and normal mucosa responses after hyperfractionated versus hypofractionated preoperative radiotherapy for rectal cancer
    Suwinski, Rafal
    Stobiecka, Ewa
    Chmielik, Ewa
    Kryj, Mariusz
    Chmielarz, Andrzej
    Widel, Maciej
    Idasiak, Adam
    Bialas, Marcin
    Wydmanski, Jerzy
    Wzietek, Iwona
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [8] Randomized Clinical Trial on Hyperfractionated Versus Hypofractionated Preoperative Radiation Therapy for Rectal Cancer: Subset Analysis and Evaluation of the Prognostic Factors for Overall Survival and Loco regional Control
    Suwinski, R.
    Wzietek, I.
    Kryj, M.
    Idasiak, A.
    Bialas, M.
    Chmielarz, A.
    Stobiecka, E.
    Chmielik, E.
    Miszczyk, L.
    Wydmanski, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S386 - S386
  • [9] Neoadjuvant chemoradiation versus hyperfractionated accelerated radiotherapy in locally advanced rectal cancer
    Ceelen, Wim
    Boterberg, Tom
    Pattyn, Piet
    van Eijkeren, Marc
    Gillardin, Jean-Marc
    Demetter, Pieter
    Smeets, Peter
    Van Damme, Nancy
    Monsaert, Els
    Peeters, Marc
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (02) : 424 - 431
  • [10] Conventional radiotherapy versus accelerated hyperfractionated radiotherapy versus conventional radiotherapy and concomitant chemotherapy in advanced oropharyngeal carcinoma: A randomized clinical trial
    Olmi, P
    Fallai, C
    Rossi, E
    Crispino, S
    Marsoni, S
    Torri, V
    Flann, M
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 420 - 420